Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Irie

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Hybridoma|February 1, 1995
Peptides with carboxyl-terminal sequence of alanine-proline: detection by a human monoclonal antibodyY Kikumoto, T Oka, J N Cao, et al.
Glycoconjugate Journal|April 1, 1994
An improved method for the measurement of total lipid-bound sialic acids after cleavage of alpha 2,8 sialic acid linkage with Vibrio cholerae sialidase in the presence of cholic acid, SDS and Ca2+M A Maliakal, M H Ravindranath, R F Irie, et al.
Cancer Research|July 1, 1994
Human monoclonal antibody identified an immunoreactive tetrapeptide sequence (Lys-Tyr-Gln-Ile) in M(r) 43,000 protein of human melanomaT Oka, Y Kikumoto, K Itakura, et al.
Cellular Immunology|July 1, 1990
Generation of lymphokine-activated killer cell activity by low-dose recombinant interleukin-2 and tumor cellsS Yamamoto, D S Hoon, P Chandler, et al.
Journal of Surgical Oncology|March 1, 1982
Comparison of the techniques used for monitoring humoral immunity in cancer patientsC M Renk, R K Gupta, R F Irie, et al.
The Journal of Biological Chemistry|May 15, 1987
Monoclonal antibody detects monosialogangliosides having a sialic acid alpha 2----3-galactosyl residueT Tai, L Sze, I Kawashima, et al.
Clinical and Experimental Immunology|January 1, 1980
A serologic study of cultured breast cancer cell lines: lack of antibody response to tumour specific membrane antigens in patientsM Higuchi, D S Robinson, R Cailleau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patientsN Morioka, Y Kikumoto, D S Hoon, et al.
Cancer Research|October 15, 1991
Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomasD S Hoon, E Okun, M Banez, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Radioimmunodetection of human melanoma tumor xenografts with human monoclonal antibodiesM Gomibuchi, R E Saxton, R R Lake, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Hybridoma|February 1, 1995
Peptides with carboxyl-terminal sequence of alanine-proline: detection by a human monoclonal antibodyY Kikumoto, T Oka, J N Cao, et al.
Glycoconjugate Journal|April 1, 1994
An improved method for the measurement of total lipid-bound sialic acids after cleavage of alpha 2,8 sialic acid linkage with Vibrio cholerae sialidase in the presence of cholic acid, SDS and Ca2+M A Maliakal, M H Ravindranath, R F Irie, et al.
Cancer Research|July 1, 1994
Human monoclonal antibody identified an immunoreactive tetrapeptide sequence (Lys-Tyr-Gln-Ile) in M(r) 43,000 protein of human melanomaT Oka, Y Kikumoto, K Itakura, et al.
Cellular Immunology|July 1, 1990
Generation of lymphokine-activated killer cell activity by low-dose recombinant interleukin-2 and tumor cellsS Yamamoto, D S Hoon, P Chandler, et al.
Journal of Surgical Oncology|March 1, 1982
Comparison of the techniques used for monitoring humoral immunity in cancer patientsC M Renk, R K Gupta, R F Irie, et al.
The Journal of Biological Chemistry|May 15, 1987
Monoclonal antibody detects monosialogangliosides having a sialic acid alpha 2----3-galactosyl residueT Tai, L Sze, I Kawashima, et al.
Clinical and Experimental Immunology|January 1, 1980
A serologic study of cultured breast cancer cell lines: lack of antibody response to tumour specific membrane antigens in patientsM Higuchi, D S Robinson, R Cailleau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patientsN Morioka, Y Kikumoto, D S Hoon, et al.
Cancer Research|October 15, 1991
Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomasD S Hoon, E Okun, M Banez, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Radioimmunodetection of human melanoma tumor xenografts with human monoclonal antibodiesM Gomibuchi, R E Saxton, R R Lake, et al.
Pageof 8